Announce Date | 05/01/2024 |
EPS Normalized Actual | $2.44 (Beat by $0.11) |
EPS GAAP Actual | $2.44 (Beat by $0.11) |
Revenue Actual | $11.164B |
Revenue Surprise | Beat by $11164M |
Announce Date | 06/23/2024 (Pre-Market) |
EPS Normalized Estimate | $2.16836 |
EPS GAAP Estimate | $2.16836 |
Revenue Estimate | $9.042909336B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Sep 2026 | 9.85276 | 18.7 | 8.43 | 11.07 | 6 |
Sep 2025 | 8.71133 | 21.15 | 6.93 | 9.96 | 17 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | 2.61 | 2.61 | 11.164B | 28.92% | 11164M |
FQ4 2021 (Dec 2021) | 3.02 | 3.02 | 10.705B | 23.07% | 10705M |
FQ3 2021 (Sep 2021) | 2.48 | 2.48 | 9.336B | 10.6% | 9336M |
FQ2 2021 (Jun 2021) | 1.8 | 1.8 | 8.06B | 39.29% | 8060M |
FQ1 2021 (Mar 2021) | 1.55 | 1.55 | 7.935B | 34.27% | 7935M |
FQ4 2020 (Dec 2020) | 2.16 | 2.16 | 8.235B | 38.35% | 8235M |
FQ3 2020 (Sep 2020) | 2.62 | 2.62 | 8.346B | 42.32% | 8346M |
FQ2 2020 (Jun 2020) | 0.75 | 0.75 | 4.893B | -96.91% | 4893M |
FQ4 Announce Date
06/23/2024 (Pre-Market)
Consensus EPS Estimates
2.16836
Consensus Revenue Estimates
9.042909336B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 2.89367 | -- | 2.77007 | 3.00912 | 6 |
FQ2 2026 (Jun 2026) | 2.63395 | -- | 2.52144 | 2.73904 | 6 |
FQ1 2026 (Mar 2026) | 2.71576 | -- | 2.59976 | 2.82411 | 6 |
FQ4 2025 (Dec 2025) | 3.00192 | -- | 2.8737 | 3.12169 | 8 |
FQ3 2025 (Sep 2025) | 2.81238 | -- | 2.69225 | 2.92459 | 8 |
FQ2 2025 (Jun 2025) | 2.50911 | -- | 2.40194 | 2.60922 | 8 |
FQ1 2025 (Mar 2025) | 2.58743 | -- | 2.47691 | 2.69066 | 8 |
FQ4 2024 (Dec 2024) | 2.84501 | -- | 2.72349 | 2.95852 | 12 |
FQ3 2024 (Sep 2024) | 2.50436 | -- | 2.39739 | 2.60428 | 12 |
FQ2 2024 (Jun 2024) | 2.16836 | -- | 2.0651 | 2.21999 | 15 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 10.93B | -- | 10.57B | 11.27B | 7 |
FQ2 2026 (Jun 2026) | 10.36B | -- | 10.02B | 10.68B | 7 |
FQ1 2026 (Mar 2026) | 10.39B | -- | 10.05B | 10.71B | 7 |
FQ4 2025 (Dec 2025) | 11.04B | -- | 10.68B | 11.38B | 7 |
FQ3 2025 (Sep 2025) | 10.73B | -- | 10.38B | 11.06B | 7 |
FQ2 2025 (Jun 2025) | 9.99B | -- | 9.66B | 10.3B | 7 |
FQ1 2025 (Mar 2025) | 10.14B | -- | 9.81B | 10.45B | 7 |
FQ4 2024 (Dec 2024) | 10.56B | -- | 10.21B | 10.88B | 13 |
FQ3 2024 (Sep 2024) | 9.83B | -- | 9.51B | 10.14B | 13 |
FQ2 2024 (Jun 2024) | 9.04B | -- | 8.71B | 9.31B | 15 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | 2.61 | 2.61 | 100% | |
FQ4 2021 (Dec 2021) | 3.02 | 3.02 | 100% | |
FQ3 2021 (Sep 2021) | 2.48 | 2.48 | 100% | |
FQ2 2021 (Jun 2021) | 1.8 | 1.8 | 100% | |
FQ1 2021 (Mar 2021) | 1.55 | 1.55 | 100% | |
FQ4 2020 (Dec 2020) | 2.16 | 2.16 | 100% | |
FQ3 2020 (Sep 2020) | 2.62 | 2.62 | 100% | |
FQ2 2020 (Jun 2020) | 0.75 | 0.75 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $11.16B | $11164M | 100% |
FQ4 2021 (Dec 2021) | $0B | $10.71B | $10705M | 100% |
FQ3 2021 (Sep 2021) | $0B | $9.34B | $9336M | 100% |
FQ2 2021 (Jun 2021) | $0B | $8.06B | $8060M | 100% |
FQ1 2021 (Mar 2021) | $0B | $7.94B | $7935M | 100% |
FQ4 2020 (Dec 2020) | $0B | $8.24B | $8235M | 100% |
FQ3 2020 (Sep 2020) | $0B | $8.35B | $8346M | 100% |
FQ2 2020 (Jun 2020) | $0B | $4.89B | $4893M | 100% |